Regular Article
Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview

https://doi.org/10.1054/plef.2001.0352Get rights and content

Abstract

The current review evaluates the evidence that some of the pharmacological and behavioral effects of ethanol (EtOH), including EtOH-preferring behavior, may be mediated through the endocannabinoid signaling system. The recent advances in the understanding of the neurobiological basis of alcoholism suggest that the pharmacological and behavioral effects of EtOH are mediated through its action on neuronal signal transduction pathways and ligand-gated ion channels, receptor systems, and receptors that are coupled to G-proteins. The identification of a G-protein-coupled receptor, namely, the cannabinoid receptor (CB1 receptor) that was activated by Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive component of marijuana, led to the discovery of endogenous cannabinoid agonists. To date, two fatty acid derivatives identified to be arachidonylethanolamide (AEA) and 2-arachidonylglycerol (2-AG) have been isolated from both nervous and peripheral tissues. Both these compounds have been shown to mimic the pharmacological and behavioral effects of Δ9-THC. The involvement of the endocannabinoid signaling system in the development of tolerance to the drugs of abuse including EtOH has not been known until recently. Recent studies from our laboratory have demonstrated for the first time the down-regulation of CB1 receptor function and its signal transduction by chronic EtOH. The observed down-regulation of CB1 receptor binding and its signal transduction results from the persistent stimulation of the receptors by the endogenous CB1 receptor agonists, AEA and 2-AG, the synthesis of which has been found to be increased by chronic EtOH treatment. This enhanced formation of endocannabinoids may subsequently influence the release of neurotransmitters. It was found that the DBA/2 mice, known to avoid EtOH intake, have significantly reduced brain-CB1-receptor function consistent with other studies, where the CB1 receptor antagonist SR141716A has been shown to block voluntary EtOH intake in rodents. Similarly, activation of the CB1 receptor system promoted alcohol craving, suggesting a role for the CB1 receptor gene in excessive EtOH drinking behavior and development of alcoholism. Ongoing investigations may lead to the development of potential therapeutic strategies for the treatment of alcoholism.

References (165)

  • L.D. Reid et al.

    Tests of opioid deficiency hypotheses of alcoholism

    Alcohol

    (1991)
  • R.D. Myers et al.

    Ethanol preference in the rat: interactions between brain serotonin and ethanol, acetaldehyde, paraldehyde, 5-HTP and 5-HTOL

    Neuropharmacology

    (1972)
  • M.R. Lu et al.

    Ethanol consumption following acute fenfluramine, fluoxetine, and dietary tryptophan

    Pharmacol Biochem Behav

    (1993)
  • H. Hodges et al.

    The effects of cholinergic drugs and cholinergic-rich fetal neural transplants on alcohol-induced deficits in radial maze performance in rats

    Behav Brain Res

    (1991)
  • F. Melis et al.

    Chronic ethanol consumption in rats: correlation between memory performance and hippocampal acetylcholine release in vivo

    Neuroscience

    (1996)
  • V. Di Marzo

    ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible

    Biochim Biophys Acta

    (1998)
  • R. Mechoulam et al.

    Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

    Biochem Pharmacol

    (1995)
  • T. Sugiura et al.

    2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

    Biochem Biophys Res Commun

    (1995)
  • T. Maejima et al.

    Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals

    Neurosci Res

    (2001)
  • T. Ohno-Shosaku et al.

    Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals

    Neuron

    (2001)
  • V. Di Marzo et al.

    Anandamide, an endogenous cannabinomimetic eicosanoid: ‘killing two birds with one stone’

    Prostaglandins Leukot Essent Fatty Acids

    (1995)
  • J.N. Crawley et al.

    Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents

    Pharmacol Biochem Behav

    (1993)
  • T. Sugiura et al.

    2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells

    Biochem Biophys Res Commun

    (1996)
  • C.A. Audette et al.

    G-protein mediation of cannabinoid-induced phospholipase activation

    Pharmacol Biochem Behav

    (1991)
  • S. Burstein et al.

    Phospholipase participation in cannabinoid-induced release of free arachidonic acid

    Biochem Pharmacol

    (1994)
  • M. Wartmann et al.

    The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

    FEBS Lett

    (1995)
  • C.A. Gebhardt et al.

    Computerized measures of CT scans of alcoholics: thalamic region related to memory

    Alcohol

    (1984)
  • B.S. Basavarajappa et al.

    Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane

    Brain Res

    (1998)
  • B.S. Basavarajappa et al.

    Down-regulation of cannabinoid receptor agonist-stimulated [35S] GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse

    Brain Res

    (1999)
  • B.S. Basavarajappa et al.

    Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2

    Biochem Pharmacol

    (1998)
  • B.L. Hungund et al.

    Formation of fatty acid ethyl esters during chronic ethanol treatment in mice

    Biochem Pharmacol

    (1988)
  • B.S. Basavarajappa et al.

    Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons

    Biochemica Biophysica Acta

    (2000)
  • P. Schmid et al.

    Occurrence and postmortem generation of anandamide and other long-chain N -acylethanolamines in mammalian brain

    FEBS Lett

    (1995)
  • C. Felder et al.

    Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat

    FEBS Lett

    (1996)
  • S.A. Hunter et al.

    Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

    Life Sci

    (1997)
  • C. Lundqvist et al.

    Phosphatidylethanol formation and degradation in brains of acutely and repeatedly ethanol-treated rats

    Neurosci Lett

    (1994)
  • V. Di Marzo et al.

    Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action

    Trends Neurosci

    (1998)
  • P. Mailleux et al.

    Delta-9-Tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamen

    Eur J Pharmacol

    (1994)
  • Y.P. Maneuf et al.

    Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus

    Eur J Pharmacol

    (1996)
  • E.L. Gardner et al.

    Cannabinoid transmission and reward-related events

    Neurobiol Dis

    (1998)
  • R. Mechoulam et al.

    Endocannabinoids

    Eur J Pharmacol

    (1998)
  • H. Hansen et al.

    Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N -acylethanolamine in cortical neurons in culture

    Biochim Biophys Acta

    (1995)
  • A. Oviedo et al.

    Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study

    Brain Res

    (1993)
  • F. Fan et al.

    Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice

    Brain Res

    (1996)
  • J. Romero et al.

    Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions

    Brain Res Mol Brain Res

    (1997)
  • J. Romero et al.

    Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5′O -(thio)-triphosphate binding in the basal ganglia of aged rats

    Neuroscience

    (1998)
  • R.O. Messing et al.

    Molecular biology of alcohol dependence

  • N.P. Franks et al.

    Molecular and cellular mechanisms of general anesthesia

    Nature

    (1994)
  • P.L. Hoffman

    Glutamate receptors in alcohol withdrawal-induced neurotoxicity

    Metab Brain Dis

    (1995)
  • F. Fadda et al.

    Ethanol–stress interaction on dopamine metabolism in the medial prefrontal cortex

    Alcohol Drug Res

    (1985)
  • Cited by (76)

    • Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol

      2018, Biochemical Pharmacology
      Citation Excerpt :

      This assumption may explain the possible correlation between CB2r-mediated changes in ethanol consumption and motivation, and the opposite OPRM1 gene expression modifications obtained in this study. The endogenous cannabinoid system appears to be implicated in the vulnerability and development of ethanol consumption [2–4,67,68]. Real time PCR analyses revealed an increase of CB1r gene expression in AM630-treated animals while the treatment with JWH133 produced the opposite effect.

    • Cannabinoids and drug addiction

      2015, Cannabinoids in Neurologic and Mental Disease
    • Effects of Ethanol Exposure on Nervous System Development in Zebrafish

      2012, International Review of Cell and Molecular Biology
    • CB1 receptors regulate alcohol-seeking behavior and alcohol self-administration of alcohol-preferring (P) rats

      2011, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Alcohol and Δ9 tetrahydrocannabinol (THC), the main psychoactive constituent of marijuana, activate similar reward pathways (Gessa et al., 1998). There also exists cross-tolerance between alcohol and THC suggestive of the involvement of possible common pathway(s) (Basavarajappa and Hungund, 2002). One of the systems that are activated by both alcohol and CBs/THC is the endogenous cannabiniod (CB) system.

    • The effects of alcoholism on the human basolateral amygdala

      2010, Neuroscience
      Citation Excerpt :

      Astrocyte loss may also contribute to the decreased expression of the glutamate transporters in alcoholic subjects or it may be possible that lower expression of these transporters pre-existed the alcoholism and contributed to it. Another factor may be ethanol-induced increases in the endocannabinoid anandamide (Basavarajappa and Hungund, 1999) which was shown to inhibit both GLAST and GLT-1 (Shivachar, 2007) as well as downregulate the cannabinoid receptor 1 (CB1) (Basavarajappa and Hungund, 2002; Ortiz et al., 2004). CB1 receptors were downregulated in the alcoholic patients in this microarray study.

    View all citing articles on Scopus
    f1

    Correspondence to: Basalingappa L. Hungund, Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA. Tel.: +1-845-398-5452 or 5454; Fax: +1-845-398-5451; E-mail: [email protected]; [email protected]

    View full text